trademark “Wuttisak Clinic”, which start operate the franchise business on February 10, 2018. So far we can generate income for each branch continuously. 3. Analysis of Operating Results Statements of
Consolidated Interim Financial Statements the three-month and the nine-month period ended 30 September 2019, which have been reviewed by the Company’s authorized auditor. The company would like to clarify the
statements Q1-2022 Q1-2023 THB Mn THB Mn THB Mn % Sales of goods and services 1,518.7 1,638.2 119.5 7.9% Revenue from finance lease under power purchase agreement 102.3 102.4 0.1 0.1% Cost of sales and
1 Ref. No. IVL 006/11/2017 9 Nov 2017 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Reviewed Financial Statements and the Management Discussion and Analysis of
1 Ref. No. IVL 005/02/2018 20 Feb 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama
1 Ref. No. IVL 005/02/2018 20 Feb 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama
Ref. No. IVL 002/05/2019 7 May 2019 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review Financial Statements and the Management Discussion and Analysis of Indorama
Ref. No. IVL 002/05/2019 7 May 2019 The President The Stock Exchange of Thailand Subject: Submission of Quarterly Review Financial Statements and the Management Discussion and Analysis of Indorama
Ref. No. IVL 007/08/2018 Aug 6, 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama
Ref. No. IVL 002/11/2018 Nov 8, 2018 The President The Stock Exchange of Thailand Subject: Submission of Annual Audited Financial Statements and the Management Discussion and Analysis of Indorama